Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
Clinical trial NCT03488706 · UNKNOWN
Trial details
- NCT number
- NCT03488706
- Sponsor
- CellMaxLife
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-01-17
- Primary completion
- 2018-12-12
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.